---
title: Biolivz Research Center Private Limited vs GemPharmatech
slug_a: biolivz
slug_b: gempharmatech
site: cro
review_signal_gate: closed
canonical_path: /compare/biolivz/gempharmatech
---

# Biolivz Research Center Private Limited vs GemPharmatech

Side-by-side profile data from each company listing on this directory.

## Biolivz Research Center Private Limited

- Profile: [/companies/biolivz](/companies/biolivz)

Biolivz Research Center Private Limited — Biolivz Research Center is a preclinical contract research organization in Telangana, India. It offers in vitro ADME, in vivo pharmacokinetics and toxicokinetics, bioanalysis, in vivo pharmacology, and strategic services to drug development clients.

Services: 5. Modalities: 0. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (5).

### Services

- In Vitro Pharmacology
- In Vitro ADME / DMPK
- Preclinical In Vivo Studies
- In Vivo PK / PD Studies
- Bioanalysis

### Modalities

- Data not yet provided.

### Indications

- Data not yet provided.

### Phases

- Preclinical (General)

### Sourcing models

- Data not yet provided.

## GemPharmatech

- Profile: [/companies/gempharmatech](/companies/gempharmatech)

GemPharmatech — GemPharmatech develops and supplies genetically engineered mouse models (GEMMs) and preclinical research services using CRISPR/Cas9 and gene-editing technologies, with a library of 25,000+ mouse strains including KO/cKO, humanized, and immunodeficient models.

Services: 7. Modalities: 1. Indications: 7. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (7).

### Services

- Target Identification & Validation
- Preclinical In Vitro Studies
- In Vitro Pharmacology
- Preclinical In Vivo Studies
- In Vivo Efficacy Models
- In Vivo PK / PD Studies
- Specialized & Large-Animal Models

### Modalities

- Biologics (Monoclonal Antibodies)

### Indications

- Oncology
- Immunology
- Neurology
- Metabolic
- Cardiovascular
- Infectious Disease
- Rare Disease

### Phases

- Preclinical (General)
- Preclinical (IND-Enabling)

### Sourcing models

- Full-Service Outsourcing (FSO)